How do alkylating agents operate in chemotherapy?

How do alkylating agents operate in chemotherapy?

• A. By inhibiting cell division
• B. By damaging DNA by adding alkyl groups
• C. By mimicking natural hormones
• D. By blocking blood vessel growth

Answer: (B)

Alkylating agents operate in chemotherapy primarily by damaging DNA through the process of adding alkyl groups to DNA molecules. This action forms covalent bonds with DNA bases, usually guanine, leading to the formation of cross-links. These cross-links prevent the DNA from unwinding properly, which is essential for replication and transcription. As a result, the damaged DNA triggers cellular mechanisms that can lead to cell cycle arrest and ultimately apoptosis, or programmed cell death. The effectiveness of alkylating agents stems from their ability to target rapidly dividing cancer cells, which are more vulnerable to DNA damage than normal cells. This mechanism distinguishes alkylating agents from other classes of chemotherapy drugs that may operate differently, such as those that inhibit cell division or mimic natural hormones.

Alkylating agents operate in chemotherapy primarily by damaging DNA through the process of adding alkyl groups to DNA molecules. This action forms covalent bonds with DNA bases, usually guanine, leading to the formation of cross-links. These cross-links prevent the DNA from unwinding properly, which is essential for replication and transcription. As a result, the damaged DNA triggers cellular mechanisms that can lead to cell cycle arrest and ultimately apoptosis, or programmed cell death. The effectiveness of alkylating agents stems from their ability to target rapidly dividing cancer cells, which are more vulnerable to DNA damage than normal cells. This mechanism distinguishes alkylating agents from other classes of chemotherapy drugs that may operate differently, such as those that inhibit cell division or mimic natural hormones.